1.
Wollenberg A, Guttman-Yassky E, Torpet M, Silverberg JI. Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis. J of Skin [Internet]. 2018 Dec. 17 [cited 2024 Jul. 4];2:S63. Available from: https://jofskin.org/33014/index.php/skin/article/view/459